background image

Paid Clinical Trials Irving

Discover 1,809 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Featured

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 10 - 17

Code: NCT06372964

Phase3, Recruiting
FeaturedActive & Responsive

Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.

for
Diabetic Foot Ulcer (DFU), Amnio-Maxx
Location: 8 recruiting locations
Sponsor: Royal Biologics

Sex: All

Age: 18+

Code: NCT07209475

Recruiting
Active & ResponsiveNew

A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU)

for
Phenylketonuria
Location: 2 recruiting locations
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 18+

Code: NCT06971731

Phase3, Recruiting
Active & ResponsiveNew

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

for
Atopic Dermatitis (AD), Psoriasis (PsO)
Location: 2 recruiting locations
Sponsor: LAPIX Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06982352

Phase1, Recruiting
Active & ResponsiveNew

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

for
Congenital Adrenal Hyperplasia,
Location: 3 recruiting locations
Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All

Age: 1 - 17

Code: NCT07159841

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & ResponsiveNew

Taldefgrobep Alfa in Adults With Overweight and Obesity

for
Obesity, Overweight
Location: 10 recruiting locations
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 65

Code: NCT07281495

Phase2, Recruiting
Active & Responsive

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: 21 recruiting locations
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT05787587

Phase1, Recruiting
Active & Responsive

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

for
Triple Negative Breast Cancer (TNBC),
Location: 9 recruiting locations
Sponsor: Boundless Bio

Sex: All

Age: 18+

Code: NCT05827614

Phase1, Recruiting
Active & Responsive

PAS-004 in Patients With Advanced Solid Tumors

for
RAS Mutation, NF1 Mutation, RAF Mutation, Advanced Solid Tumors
Location: 3 recruiting locations
Sponsor: Pasithea Therapeutics Corp.

Sex: All

Age: 18+

Code: NCT06299839

Phase1, Recruiting
Active & Responsive

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

for
Prostate Cancer Castration-resistant Prostate Cancer,
Location: 5 recruiting locations
Sponsor: MBrace Therapeutics

Sex: All

Age: 18+

Code: NCT07145255

Phase1, Phase2, Recruiting